Prevalence and Risk Factors for School-Associated Transmission of SARS-CoV-2 [0.03%]
学校关联SARS-CoV-2传播的流行率及危险因素分析
Sandra B Nelson,Caitlin M Dugdale,Isaac Ravi Brenner et al.
Sandra B Nelson et al.
Importance: School-associated SARS-CoV-2 transmission is described as uncommon, although the true transmission rate is unknown. Objective: ...
The FDA Declares Levonorgestrel a Nonabortifacient-A 50-Year Saga Takes a Decisive Turn [0.03%]
FDA声明左旋诺孕酯不是流产药物-一段50年的历史迎来了决定性的转折点
Eli Y Adashi,I Glenn Cohen,Allen J Wilcox
Eli Y Adashi
Lawrence O Gostin,Sarah Wetter,Rebecca B Reingold
Lawrence O Gostin
Error in Study Type [0.03%]
研究类型错误
Published Erratum
JAMA health forum. 2023 Jul 7;4(7):e232428. DOI:10.1001/jamahealthforum.2023.2428 2023
Evaluation of the Conrad 30 Waiver Program's Success in Attracting International Medical Graduates to Underserved Areas [0.03%]
康拉德30豁免计划吸引国际医学毕业生前往服务欠缺地区的效果评估
Tarun Ramesh,Sarah E Brotherton,Gregory D Wozniak et al.
Tarun Ramesh et al.
Association of State Funding for Comprehensive Reproductive Health Care With Use of Contraception Among Latina Patients and Non-Latina Patients in Oregon [0.03%]
俄勒冈州公共资金资助综合生殖健康护理与拉美裔患者和非拉美裔患者避孕药具使用情况的关系
Megan A Cohen,Emily R Boniface,Megan Skye et al.
Megan A Cohen et al.
Importance: There are well-documented racial and ethnic disparities in effective contraceptive use due to multiple factors. A key contributor may be differential insurance coverage and patient costs. The Oregon Reproducti...
Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder [0.03%]
远程医疗环境中用于治疗阿片类药物使用障碍的尿药检筛查
Arthur Robin Williams,Christopher Rowe,Ryan Gallagher et al.
Arthur Robin Williams et al.
Importance: Amid rapid and widespread adoption of telehealth-based opioid treatment (TBOT), there is an urgent need for rigorous studies exploring the feasibility and characteristics of urine drug screening (UDS). ...
Observational Study
JAMA health forum. 2023 Jul 7;4(7):e232247. DOI:10.1001/jamahealthforum.2023.2247 2023
Preparing for the International Classification of Diseases, 11th Revision (ICD-11) in the US Health Care System [0.03%]
美国医疗体系中的国际疾病分类第11版（ICD-11）准备工作的开展
James A Feinstein,Peter J Gill,Brett R Anderson
James A Feinstein
Stuart M Butler
Stuart M Butler